GLP-1R Signaling and Functional Molecules in Incretin Therapy
Weight loss results vary by drug, with Rybelsus producing more modest losses (~6% in a year) and Foundayo and Wegovy producing results on par with injections (up to ~11%--14% in a year, respectively)
Diabetes Obes Metab 22(12):24872492 Verma S, Bhatta M, Davies M, Deanfield JE, Garvey WT, Jensen C, et al (2023) Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials
GLP-1 weight loss injections are available at Set Point Medical Weight Loss Clinic in Folsom, CA
Ozempic and Wegovy created enormous brand recognition, and oral semaglutide gives Novo a major lever in the pill-based obesity market
This is because in addition to reducing and controlling appetite, it also stimulates another hormone, GIP, which is thought to improve how the body breaks down sugar and fat
